These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23485336)

  • 1. Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry.
    Goudreau N; Hucke O; Faucher AM; Grand-Maître C; Lepage O; Bonneau PR; Mason SW; Titolo S
    J Mol Biol; 2013 Jun; 425(11):1982-1998. PubMed ID: 23485336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.
    Kim MJ; Kim SH; Park JA; Yu KL; Jang SI; Kim BS; Lee ES; You JC
    Retrovirology; 2015 Nov; 12():90. PubMed ID: 26545586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition.
    Amarasinghe GK; De Guzman RN; Turner RB; Chancellor KJ; Wu ZR; Summers MF
    J Mol Biol; 2000 Aug; 301(2):491-511. PubMed ID: 10926523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein.
    Mori M; Schult-Dietrich P; Szafarowicz B; Humbert N; Debaene F; Sanglier-Cianferani S; Dietrich U; Mély Y; Botta M
    Virus Res; 2012 Nov; 169(2):377-87. PubMed ID: 22634301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1.
    Summers MF; Henderson LE; Chance MR; Bess JW; South TL; Blake PR; Sagi I; Perez-Alvarado G; Sowder RC; Hare DR
    Protein Sci; 1992 May; 1(5):563-74. PubMed ID: 1304355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HIV-1 inhibitors targeting the nucleocapsid protein.
    Breuer S; Chang MW; Yuan J; Torbett BE
    J Med Chem; 2012 Jun; 55(11):4968-77. PubMed ID: 22587465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nucleocapsid region in HIV-1 Gag assembly as investigated by quantitative fluorescence-based microscopy.
    de Rocquigny H; El Meshri SE; Richert L; Didier P; Darlix JL; Mély Y
    Virus Res; 2014 Nov; 193():78-88. PubMed ID: 25016037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
    Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
    ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the structure and dynamics of the capsid-spacer peptide 1-nucleocapsid fragment of the HIV-1 gag polyprotein by solution NMR spectroscopy.
    Deshmukh L; Ghirlando R; Clore GM
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1025-8. PubMed ID: 24338988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Psi-recognition element.
    Hagan N; Fabris D
    Biochemistry; 2003 Sep; 42(36):10736-45. PubMed ID: 12962498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the nucleocapsid domain in HIV-1 Gag oligomerization and trafficking to the plasma membrane: a fluorescence lifetime imaging microscopy investigation.
    El Meshri SE; Dujardin D; Godet J; Richert L; Boudier C; Darlix JL; Didier P; Mély Y; de Rocquigny H
    J Mol Biol; 2015 Mar; 427(6 Pt B):1480-1494. PubMed ID: 25644662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid Protein.
    Shvadchak V; Zgheib S; Basta B; Humbert N; Langedijk J; Morris MC; Ciaco S; Maskri O; Darlix JL; Mauffret O; Fossé P; Réal E; Mély Y
    Biochemistry; 2018 Jul; 57(30):4562-4573. PubMed ID: 30019894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation and dynamics of the Gag polyprotein of the human immunodeficiency virus 1 studied by NMR spectroscopy.
    Deshmukh L; Ghirlando R; Clore GM
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3374-9. PubMed ID: 25713345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.
    Purdy MD; Shi D; Chrustowicz J; Hattne J; Gonen T; Yeager M
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13258-13263. PubMed ID: 30530702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy.
    Stephen AG; Datta SA; Worthy KM; Bindu L; Fivash MJ; Turner KB; Fabris D; Rein A; Fisher RJ
    J Biomol Tech; 2007 Sep; 18(4):259-66. PubMed ID: 17916799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.
    Kempf N; Postupalenko V; Bora S; Didier P; Arntz Y; de Rocquigny H; Mély Y
    J Virol; 2015 Feb; 89(3):1756-67. PubMed ID: 25410868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.